Han, Mingqi
Bushong, Eric A.
Segawa, Mayuko http://orcid.org/0000-0002-5680-9576
Tiard, Alexandre
Wong, Alex
Brady, Morgan R.
Momcilovic, Milica
Wolf, Dane M.
Zhang, Ralph http://orcid.org/0000-0001-5855-1428
Petcherski, Anton
Madany, Matthew
Xu, Shili
Lee, Jason T. http://orcid.org/0000-0003-2590-2011
Poyurovsky, Masha V.
Olszewski, Kellen
Holloway, Travis http://orcid.org/0000-0002-4533-4851
Gomez, Adrian http://orcid.org/0000-0002-8982-4369
John, Maie St.
Dubinett, Steven M. http://orcid.org/0000-0003-3656-8039
Koehler, Carla M.
Shirihai, Orian S. http://orcid.org/0000-0001-8466-3431
Stiles, Linsey http://orcid.org/0000-0002-1514-458X
Lisberg, Aaron
Soatto, Stefano http://orcid.org/0000-0003-2902-6362
Sadeghi, Saman
Ellisman, Mark H. http://orcid.org/0000-0001-8893-8455
Shackelford, David B. http://orcid.org/0000-0002-8270-898X
Article History
Received: 27 January 2021
Accepted: 3 February 2023
First Online: 15 March 2023
Competing interests
: S.M.D. is an advisory board member for EarlyDx Inc., T-Cure Bioscience Inc., Cynvenio Biosystems Inc. and the Johnson and Johnson Lung Cancer Initiative. M.V.P. and K.O. are full-time employees of Kadmon Corporation. A.L. reports the following: (1) Employment Company: Boston ScientificImmediate family member (wife); (2) Stock (<5% equity) Company: Boston Scientific Immediate family member (wife); (3) Commercial Research Grants Daiichi Sankyo, Calithera Biosciences, AstraZeneca, Dracen Pharmaceuticals, WindMIL eFFECTOR Therapeutics (4) Consultant/Advisory Board AstraZeneca, Bristol-Myers Squibb, Leica Biosystems, Jazz Pharmaceuticals, Novocure, Pfizer, MorphoSys, Eli Lilly, Oncocyte, Novartis, Regeneron, Janssen Oncology, Sanofi Group of Companies. All other authors declare no competing interests.